See more : Unisource Corporate Corporation (USRC) Income Statement Analysis – Financial Results
Complete financial analysis of Cameco Corporation (CCJ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cameco Corporation, a leading company in the Uranium industry within the Energy sector.
You may be interested
- Billington Holdings Plc (BILN.L) Income Statement Analysis – Financial Results
- Ambertech Limited (AMO.AX) Income Statement Analysis – Financial Results
- 9342-8530 Québec Inc. (DGCRF) Income Statement Analysis – Financial Results
- Tarku Resources Ltd. (TRKUF) Income Statement Analysis – Financial Results
- ZAOH Company, Ltd. (9986.T) Income Statement Analysis – Financial Results
Cameco Corporation (CCJ)
About Cameco Corporation
Cameco Corporation produces and sells uranium. It operates through two segments, Uranium and Fuel Services. The Uranium segment is involved in the exploration for, mining, and milling, as well as purchase and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services. This segment also produces fuel bundles or reactor components for CANDU reactors. The company sells its uranium and fuel services to nuclear utilities in the Americas, Europe, and Asia. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.59B | 1.87B | 1.47B | 1.80B | 1.86B | 2.09B | 2.16B | 2.43B | 2.75B | 2.40B | 2.44B | 2.32B | 2.38B | 2.12B | 2.31B | 2.86B | 2.31B | 1.83B | 1.31B | 1.05B | 826.95M | 748.33M | 700.84M | 688.94M | 741.60M | 718.90M | 642.90M | 590.90M | 395.30M | 347.70M | 305.80M |
| Cost of Revenue | 1.81B | 1.63B | 1.47B | 1.69B | 1.62B | 1.80B | 1.72B | 1.97B | 2.06B | 1.76B | 1.83B | 1.60B | 1.61B | 1.13B | 1.32B | 1.52B | 1.21B | 1.13B | 814.03M | 623.12M | 538.82M | 486.16M | 422.07M | 413.88M | 428.90M | 400.60M | 316.10M | 298.20M | 190.20M | 175.00M | 146.70M |
| Gross Profit | 781.99M | 233.29M | 1.93M | 106.45M | 241.63M | 295.75M | 436.27M | 463.48M | 697.05M | 637.78M | 606.73M | 723.26M | 776.12M | 995.78M | 990.71M | 1.34B | 1.10B | 703.92M | 498.62M | 425.36M | 288.12M | 262.18M | 278.77M | 275.06M | 312.70M | 318.30M | 326.80M | 292.70M | 205.10M | 172.70M | 159.10M |
| Gross Profit Ratio | 30.22% | 12.49% | 0.13% | 5.91% | 12.97% | 14.14% | 20.23% | 19.06% | 25.31% | 26.60% | 24.88% | 31.16% | 32.55% | 46.89% | 42.80% | 46.92% | 47.54% | 38.43% | 37.99% | 40.57% | 34.84% | 35.03% | 39.78% | 39.93% | 42.17% | 44.28% | 50.83% | 49.53% | 51.88% | 49.67% | 52.03% |
| Research & Development | 21.04M | 12.18M | 7.17M | 3.97M | 6.06M | 1.76M | 5.66M | 4.95M | 6.59M | 5.04M | 7.30M | 9.30M | 100.44M | 4.79M | 630.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 245.54M | 172.03M | 127.57M | 145.34M | 124.87M | 141.55M | 163.10M | 206.65M | 186.81M | 176.39M | 184.98M | 181.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 245.54M | 172.03M | 127.57M | 145.34M | 124.87M | 141.55M | 163.10M | 206.65M | 186.81M | 176.39M | 184.98M | 181.25M | 161.84M | 155.81M | 135.56M | 120.79M | 130.84M | 166.25M | 110.43M | 71.48M | 48.73M | 43.95M | 38.74M | 40.68M | 38.00M | 42.20M | 29.10M | 26.60M | 21.20M | 18.70M | 14.10M |
| Other Expenses | 232.55M | 33.52M | -21.60M | -2.55M | 16.42M | 2.16M | -1.32M | 59.57M | -4.60M | 50.59M | -3.37M | -24.75M | 161.84M | 412.21M | 396.55M | 800.03M | 510.07M | 368.54M | 365.42M | 287.68M | 195.14M | 178.24M | 186.33M | 178.49M | 197.50M | 199.50M | 183.80M | 150.80M | 105.70M | 88.10M | 81.90M |
| Operating Expenses | 499.13M | 217.73M | 113.13M | 146.76M | 147.35M | 223.21M | 198.73M | 220.11M | 233.66M | 227.99M | 265.11M | 287.72M | 262.28M | 450.82M | 397.18M | 800.03M | 510.07M | 368.54M | 365.42M | 287.68M | 195.14M | 178.24M | 186.33M | 178.49M | 197.50M | 199.50M | 183.80M | 150.80M | 105.70M | 88.10M | 81.90M |
| Cost & Expenses | 2.30B | 1.85B | 1.59B | 1.84B | 1.77B | 2.02B | 1.92B | 2.19B | 2.29B | 1.99B | 2.10B | 1.89B | 1.87B | 1.58B | 1.72B | 2.32B | 1.72B | 1.50B | 1.18B | 910.80M | 733.96M | 664.39M | 608.40M | 592.37M | 626.40M | 600.10M | 499.90M | 449.00M | 295.90M | 263.10M | 228.60M |
| Interest Income | 87.85M | 37.50M | 6.80M | 10.84M | 29.76M | 22.07M | 5.27M | 4.38M | 5.42M | 7.40M | 6.97M | 20.75M | 24.55M | 47.72M | 6.61M | 16.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 92.05M | 69.04M | 60.71M | 57.74M | 83.93M | 96.72M | 95.23M | 95.05M | 96.51M | 93.19M | 83.21M | 72.36M | 22.00K | 49.88M | 40.74M | 53.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 220.32M | 229.00M | 203.36M | 246.95M | 299.12M | 411.10M | 352.25M | 392.33M | 312.52M | 338.98M | 282.76M | 293.43M | 274.84M | 251.55M | 240.64M | 293.31M | 225.54M | 199.66M | 197.52M | 180.23M | 124.49M | 112.76M | 129.39M | 117.01M | 136.90M | 126.70M | 122.70M | 95.00M | 67.50M | 57.50M | 58.00M |
| EBITDA | 799.52M | 307.74M | 147.27M | 201.92M | 430.45M | 464.62M | 218.34M | 312.50M | 754.48M | 313.07M | 615.96M | 479.72M | 808.43M | 833.95M | 1.05B | 1.20B | 813.55M | 535.04M | 411.74M | 315.64M | 217.47M | 196.70M | 221.83M | 213.57M | 252.10M | 245.50M | 265.70M | 236.90M | 166.90M | 142.10M | 135.20M |
| EBITDA Ratio | 30.90% | 16.47% | 9.36% | 11.22% | 23.11% | 21.13% | 25.80% | 27.23% | 27.91% | 32.16% | 29.54% | 30.64% | 30.73% | 38.98% | 34.72% | 41.85% | 45.68% | 24.75% | 27.00% | 17.40% | 26.68% | 26.05% | 31.45% | 52.20% | 40.40% | 35.16% | 39.48% | 39.75% | 40.30% | 40.72% | 43.85% |
| Operating Income | 282.86M | 130.36M | -52.32M | -6.75M | 154.70M | 70.24M | -127.73M | -141.79M | 245.58M | 38.33M | 264.69M | 269.21M | 506.24M | 542.80M | 2.13B | 524.17M | 475.01M | 335.38M | 39.66M | 260.63M | 92.98M | 83.94M | 92.44M | -51.39M | 69.70M | 102.80M | 143.00M | 141.90M | 99.40M | 84.60M | 77.20M |
| Operating Income Ratio | 10.93% | 6.98% | -3.55% | -0.37% | 8.30% | 3.36% | -5.92% | -5.83% | 8.92% | 1.60% | 10.85% | 11.60% | 21.23% | 25.56% | 91.92% | 18.33% | 20.57% | 18.31% | 3.02% | 24.86% | 11.24% | 11.22% | 13.19% | -7.46% | 9.40% | 14.30% | 22.24% | 24.01% | 25.15% | 24.33% | 25.25% |
| Total Other Income/Expenses | 204.29M | -45.57M | 32.36M | 39.20M | 42.61M | -30.31M | -79.50M | -12.45M | -324.84M | -157.43M | -149.56M | -68.09M | -44.64M | -11.15M | -36.91M | -182.62M | -9.08M | 10.05M | 151.79M | 118.89M | 91.70M | 9.95M | 15.12M | 7.55M | 7.60M | -9.90M | 4.10M | 900.37K | 6.20M | -400.00K | -1.40M |
| Income Before Tax | 487.15M | 84.80M | -103.86M | -39.53M | 135.02M | 39.93M | -207.24M | -154.23M | -79.27M | -119.10M | 227.93M | 218.21M | 450.39M | 531.65M | 766.86M | 484.90M | 465.93M | 345.43M | 274.63M | 379.52M | 196.60M | 104.33M | 107.56M | -43.84M | 77.30M | 92.90M | 147.10M | 142.80M | 105.60M | 84.20M | 75.80M |
| Income Before Tax Ratio | 18.83% | 4.54% | -7.04% | -2.20% | 7.25% | 1.91% | -9.61% | -6.34% | -2.88% | -4.97% | 9.35% | 9.40% | 18.89% | 25.03% | 33.13% | 16.96% | 20.17% | 18.86% | 20.92% | 36.20% | 23.77% | 13.94% | 15.35% | -6.36% | 10.42% | 12.92% | 22.88% | 24.17% | 26.71% | 24.22% | 24.79% |
| Income Tax Expense | 126.34M | -4.47M | -1.20M | 13.67M | 61.08M | -126.31M | -2.52M | -94.36M | -142.63M | -175.27M | -89.76M | -46.38M | -24.00K | 27.25M | 52.90M | -24.75M | 29.47M | -68.84M | 30.26M | 73.29M | -15.99M | 48.87M | 42.34M | 34.50M | -2.70M | 47.30M | 65.10M | 5.30M | 3.50M | 3.10M | 2.80M |
| Net Income | 360.85M | 89.38M | -102.65M | -53.20M | 74.00M | 166.32M | -204.94M | -61.61M | 65.29M | 185.23M | 318.50M | 266.14M | 450.40M | 514.75M | 1.10B | 450.12M | 416.11M | 375.72M | 217.63M | 278.78M | 216.01M | 55.46M | 65.22M | -78.34M | 80.00M | 45.60M | 82.00M | 137.50M | 102.10M | 81.10M | 73.00M |
| Net Income Ratio | 13.94% | 4.78% | -6.96% | -2.96% | 3.97% | 7.95% | -9.50% | -2.53% | 2.37% | 7.73% | 13.06% | 11.46% | 18.89% | 24.24% | 47.49% | 15.74% | 18.02% | 20.51% | 16.58% | 26.59% | 26.12% | 7.41% | 9.31% | -11.37% | 10.79% | 6.34% | 12.75% | 23.27% | 25.83% | 23.32% | 23.87% |
| EPS | 0.83 | 0.22 | -0.26 | -0.13 | 0.19 | 0.42 | -0.52 | -0.16 | 0.16 | 0.47 | 0.81 | 0.64 | 1.14 | 1.31 | 2.83 | 1.29 | 1.18 | 1.07 | 0.62 | 0.81 | 1.24 | 0.13 | 0.17 | -0.26 | -0.14 | -0.08 | 0.25 | 0.43 | 0.32 | 0.26 | 0.23 |
| EPS Diluted | 0.83 | 0.22 | -0.26 | -0.13 | 0.19 | 0.42 | -0.52 | -0.16 | 0.16 | 0.47 | 0.81 | 0.64 | 1.14 | 1.30 | 2.82 | 1.28 | 1.13 | 1.02 | 0.60 | 0.78 | 1.22 | 0.13 | 0.17 | -0.26 | -0.14 | -0.08 | 0.25 | 0.43 | 0.32 | 0.26 | 0.23 |
| Weighted Avg Shares Out | 433.38M | 405.49M | 397.63M | 395.83M | 395.80M | 395.79M | 394.12M | 385.07M | 395.79M | 395.74M | 395.43M | 395.23M | 394.66M | 393.17M | 387.96M | 350.13M | 352.64M | 351.14M | 347.53M | 341.37M | 336.38M | 291.51M | 332.06M | 299.38M | 388.21M | 343.91M | 326.15M | 317.63M | 314.47M | 312.24M | 313.17M |
| Weighted Avg Shares Out (Dil) | 435.36M | 407.14M | 397.63M | 395.83M | 396.06M | 396.05M | 395.79M | 395.79M | 395.79M | 396.06M | 395.55M | 395.84M | 395.48M | 395.02M | 389.93M | 352.11M | 368.24M | 368.35M | 359.12M | 354.49M | 340.92M | 291.51M | 332.06M | 299.38M | 388.21M | 343.91M | 326.15M | 317.63M | 314.47M | 312.24M | 313.17M |
Is It Worth Investing in Cameco (CCJ) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Here's Why Cameco Stock Soared in October
Google became the latest tech giant and cloud service provider to sign agreements to procure power generated by nuclear reactors in October, and that's good news for the industry at large.
Cameco (CCJ) Earnings Expected to Grow: Should You Buy?
Cameco (CCJ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cameco (CCJ) Dipped More Than Broader Market Today
In the most recent trading session, Cameco (CCJ) closed at $53.98, indicating a -1.44% shift from the previous trading day.
Cameco (CCJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Cameco (CCJ) reachead $54.77 at the closing of the latest trading day, reflecting a -0.73% change compared to its last close.
It's Time To Go Nuclear
AI's rising energy demands are driving a shift towards nuclear power, with major tech companies investing in small modular reactors (SMRs) for sustainable energy solutions. NuScale Power, Oklo, and Cameco are highlighted as key players in the nuclear sector, each...
2 Uranium Plays to Play a Nuclear Renaissance
The nuclear power utilities have really heated up as some tech titans turned to small nuclear reactors to help fuel their AI data centers of the future.
Cameco Is the Leading Play on Nuclear Power, And It Pays to Own
Cameco NYSE: CCJ is the leading player in nuclear power today because it is the leading provider of uranium. The industry would be powerless without uranium and the services that turn the raw ore into usable fuel.
Cameco: A Short-Term Dip Can Be The Perfect Buying Opportunity
Cameco's stock has surged 25% YTD, outperforming the Global X Uranium ETF's 14% rise, driven by improved Q2 2024 financials and stabilizing uranium prices. However, in the short-term there are risks ahead, including potential earnings contraction and high forward P/E...
The Big 3: CCJ, UNH, UPST
Mike Shorr of @ProsperTradingAcademy swings by with a nuclear power play: Cameco (CCJ). He says A.I. power demand will mean big things for this space, but says CCJ is a technical play. Mike also provides example trade strategies for UnitedHealth...
Source: https://incomestatements.info
Category: Stock Reports